🟢 Definium Therapeutics is trading 4.2% up today amid broader biotech strength and positive sector sentiment

Definium Therapeutics is trading at $44.09 (+4.18%) amid a firmer biotech tape and positive sector-wide earnings sentiment, despite no company-specific news identified.

• The move aligns with broader industry gains, with the XBI biotech ETF rising 2.02%.
• The stock is currently trading near the top of its recent range as the broader market remains mixed.
• No direct catalysts, such as earnings releases or FDA decisions, were identified to account for the move.